Moderna says new Covid vaccine effective against BA.2.86 variant
Moderna, Pfizer and Novavax are slated to roll out new vaccines targeting XBB.1.5 within weeks, pending approvals from the FDA.
Stay updated with breaking news from Immunizations. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Moderna, Pfizer and Novavax are slated to roll out new vaccines targeting XBB.1.5 within weeks, pending approvals from the FDA.
The news comes amid concerns about rising cases in the U.S.
Having so many mutations increased the chance that it would behave differently from previous versions of the virus, possibly making it more dangerous.
The European Commission has authorized an updated COVID-19 vaccine from Pfizer/BioNtech to be used in EU countries' vaccination campaigns this autumn to target the dominant Omicron XBB.1.5 variant.
With COVID cases rising, many are asking when they should get their next booster.